In leukemic cell survival, miRNAs-15/16 is inversely correlated with the levels of oncogenes, such as B-cell lymphoma 2 (Bcl2), which is expressed in several haematological diseases [6], myeloid cell leukemia-1 (MCL1), JUN, and WNT3a [95]. Here, MCL1 is linked to hematologic disorder.